BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Antares Pharma to Report Third Quarter 2017 Financial and Operating Results and Host Webcast and Conference Call

  Management will host a webcast and conference call at 8:30 a.m. ET on November 7, 2017 to discuss the results.

  October 31, 2017

   · 

  5 min read
• Drug Development

  Novoteris Investigator Receives Health Canada Clearance to Start a Phase IIa Clinical Trial of its Thiolanox Nitric Oxide for the Treatment of Non-Tuberculous Mycobacteria (NTM)

  This single center open label trial will recruit 10 subjects to the Vancouver clinical site.

  October 31, 2017

   · 

  3 min read
• Business

  Flex Pharma Names Dr. Roger Tung to Its Board of Directors

  Dr. Tung is the scientific co-founder of Concert Pharmaceuticals, where he serves as President and Chief Executive Officer. Prior to Concert, Dr. Tung was a founding scientist at Vertex, a pharmaceutical company.

  October 31, 2017

   · 

  3 min read
• Business

  Cerus and Kedrion Biopharma Enter Distribution Agreement for the Full INTERCEPT Blood System Portfolio in Italy

  Kedrion Biopharma will initially distribute INTERCEPT for platelets and plasma and will have the right to distribute INTERCEPT red blood cells following CE mark approval.

  October 31, 2017

   · 

  5 min read
• Oramed Granted Broad Composition of Matter Patent in Europe for Oral Proteins

  Oramed announced today the European Patent Office has issued to Oramed a notice of intent to grant a patent for broader claims for its invention titled, ‘Methods and Compositions for Oral Administration of Proteins’.

  October 31, 2017

   · 

  4 min read
• 

  Biotech Bay

  Bay Area’s VitalConnect Banks $38M Series C

  The round was led by MVM and Baxter Ventures.

  October 31, 2017

   · 

  2 min read
• Business

  PPD Awarded NIH Contract for Clinical Research Support Services

  PPD today announced it was awarded a seven-year contract under the Clinical Research Support Services program of the Division of AIDS, NIAID, part of the NIH.

  October 31, 2017

   · 

  1 min read
• Policy

  Teva Wins Generic Uceris Patent Trial

  Teva today announced that the United States District Court for the District of Delaware has ruled in the Company’s favor in patent litigation involving Teva’s abbreviated new drug application (ANDA) directed to a generic version of Valeant’s Uceris® (budesonide ER) tablets.

  October 31, 2017

   · 

  7 min read
• Drug Development

  Rhythm Announces Preliminary Data from Phase II Study of Setmelanotide for Treatment of Bardet-Biedl Syndrome

  The results are being presented at the ObesityWeek 2017 meeting held October 29 - November 2, 2017.

  October 31, 2017

   · 

  4 min read
• Genetown

  NeuroMetrix Closes $3.5 Million Equity Offering

  The Company’s common stock closed on October 30, 2017 at $1.80 per share. Proceeds of the offering will be used for commercialization of Quell, the Company’s over-the-counter wearable device for relief of chronic pain and for general working capital purposes.

  October 31, 2017

   · 

  3 min read